⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for refractory thyroid gland carcinoma

Every month we try and update this database with for refractory thyroid gland carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid CancerNCT03914300
Differentiated ...
Follicular Vari...
Poorly Differen...
Refractory Diff...
Refractory Thyr...
Tall Cell Varia...
Thyroid Gland F...
Thyroid Gland O...
Thyroid Gland P...
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Ipilimumab
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid CancerNCT05410821
Refractory Thyr...
Refractory Thyr...
Refractory Thyr...
Refractory Thyr...
177Lu-DOTA-EB-F...
177Lu-DOTA-EB-F...
177Lu-DOTA-EB-F...
18 Years - The First Affiliated Hospital of Xiamen University
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid CancerNCT04061980
BRAF NP_004324....
BRAF V600E Muta...
Metastatic Thyr...
Refractory Thyr...
Stage IV Differ...
Stage IVA Diffe...
Stage IVB Diffe...
Binimetinib
Encorafenib
Nivolumab
18 Years - Providence Health & Services
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid CancerNCT04061980
BRAF NP_004324....
BRAF V600E Muta...
Metastatic Thyr...
Refractory Thyr...
Stage IV Differ...
Stage IVA Diffe...
Stage IVB Diffe...
Binimetinib
Encorafenib
Nivolumab
18 Years - Providence Health & Services
Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryNCT00381641
Differentiated ...
Recurrent Thyro...
Refractory Thyr...
Stage III Thyro...
Stage III Thyro...
Stage IV Thyroi...
Stage IV Thyroi...
Stage IV Thyroi...
Stage IVA Thyro...
Stage IVA Thyro...
Stage IVA Thyro...
Stage IVB Thyro...
Stage IVB Thyro...
Stage IVB Thyro...
Stage IVC Thyro...
Stage IVC Thyro...
Stage IVC Thyro...
Thyroid Gland O...
Unresectable Th...
Laboratory Biom...
Pharmacogenomic...
Sunitinib
Sunitinib Malat...
18 Years - National Cancer Institute (NCI)
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment TrialNCT04284774
Malignant Solid...
Recurrent Adren...
Recurrent Ectom...
Recurrent Epend...
Recurrent Ewing...
Recurrent Hepat...
Recurrent Kidne...
Recurrent Lange...
Recurrent Malig...
Recurrent Malig...
Recurrent Medul...
Recurrent Melan...
Recurrent Neuro...
Recurrent Non-H...
Recurrent Osteo...
Recurrent Perip...
Recurrent Rhabd...
Recurrent Rhabd...
Recurrent Rhabd...
Recurrent Soft ...
Recurrent Thyro...
Recurrent WHO G...
Refractory Adre...
Refractory Epen...
Refractory Ewin...
Refractory Hepa...
Refractory Lang...
Refractory Mali...
Refractory Mali...
Refractory Medu...
Refractory Mela...
Refractory Neur...
Refractory Non-...
Refractory Oste...
Refractory Peri...
Refractory Rhab...
Refractory Rhab...
Refractory Rhab...
Refractory Soft...
Refractory Thyr...
Refractory WHO ...
Biospecimen Col...
Bone Marrow Asp...
Computed Tomogr...
Magnetic Resona...
Positron Emissi...
Radionuclide Im...
Tipifarnib
12 Months - 21 YearsNational Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: